Skip to content
healthcare.dev

Desvenlafaxine

NDC 51991-312, Desvenlafaxine Succinate, tablet, extended release, from Breckenridge Pharmaceutical, Inc.

Product NDC
51991-312
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204003
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE100 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
51991-312-0151991031201100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-01)
51991-312-10519910312101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-10)
51991-312-1151991031211100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-11)
51991-312-145199103121414 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-14)
51991-312-335199103123330 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-33)
51991-312-805199103128080 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-80)
51991-312-905199103129090 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25bdfc41-c7cb-4d16-b6a8-f102f9b8c984
  • NADAC price for package 51991031210

    GET /v1/drugs/nadac/51991031210
  • NADAC price for package 51991031233

    GET /v1/drugs/nadac/51991031233
  • NADAC price for package 51991031290

    GET /v1/drugs/nadac/51991031290

Use it

Look up 51991-312 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.